Today we presented part of our work on Angelman Syndrome at the Mondino Foundation in Pavia, during Brain Week 2024 π§ π¬
#AngelmanSyndrome#BrainWeek2024
π’#Meet Ambra Del Grosso! Ambra is a biologist working at the @neurosens_NEST group. She's dedicated to finding new treatments for neurodegenerative diseases like #Krabbe, using nanotechnology and autophagy modulation.
Every day should be #womenscienceday! #Cnr100@cnrsocial_
π―#CNR100 1923-2023 #centenarioCNR
π#25maggio | ore 9.00 | #Massa
"Il nanomondo dentro di noiβ
Seminario per le scuole curato da Ilaria Tonazzini, ricercatrice @Cnr_Nano
Tutte le informazioni su
https://t.co/6HUcXO93wh
Functional near-infrared spectroscopy is an innovative and non-invasive technique that allows us to study how the cerebral cortex is activated in response to target stimuli. We are exploring its applicability to find a biomarker of clinical readiness for #Angelmansyndrome.
New research reveals elevated ROS levels during early development in #AngelmanSyndrome alter the apoptotic capacity of neural precursor cells. This study sheds light on potential therapeutic targets for this disorder. Read more: https://t.co/DpWHZG51yb
#neuroscience#research
Meet Elena Scaffei, child neurologist and PhD student in neuroscience actively working on the InnovAS project for developing a fNIRS-based biomarker for AS #AngelmanSyndrome
Today we present Patrizia Pucci and Giovanna Di Prima, the staff who deal with the administrative and financial management of our InnovAS project. Patrizia and Giovanna both work at the Nanoscience Inst.- CNR in Pisa.